Arecor Therapeutics plc
AREC.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£10,618 | -£8,554 | -£10,542 | -£6,945 |
| Dep. & Amort. | £446 | £496 | £341 | £171 |
| Deferred Tax | £0 | £0 | £0 | £753 |
| Stock-Based Comp. | £158 | £638 | £503 | £484 |
| Change in WC | -£2,527 | £891 | -£1,659 | -£419 |
| Other Non-Cash | £3,386 | £688 | £577 | £506 |
| Operating Cash Flow | -£9,155 | -£5,841 | -£10,780 | -£5,450 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£23 | -£151 | -£345 | -£69 |
| Net Acquisitions | £0 | £0 | £284 | £0 |
| Inv. Purchases | £0 | £0 | -£8,041 | £0 |
| Inv. Sales/Matur. | £1,641 | £6,382 | £8,041 | £0 |
| Other Inv. Act. | £101 | £289 | -£7,932 | £1 |
| Investing Cash Flow | £1,719 | £6,520 | -£7,993 | -£68 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £9 | £38 | -£165 | £2,500 |
| Stock Issued | £6,417 | £0 | £6,000 | £20,002 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£778 | -£218 | -£675 | -£1,571 |
| Financing Cash Flow | £5,648 | -£180 | £5,160 | £20,931 |
| Forex Effect | -£66 | -£171 | £62 | £5 |
| Net Chg. in Cash | -£1,854 | £328 | -£13,551 | £15,418 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £5,093 | £4,765 | £18,316 | £2,898 |
| End Cash | £3,239 | £5,093 | £4,765 | £18,316 |
| Free Cash Flow | -£9,178 | -£5,992 | -£11,125 | -£5,519 |